P568: The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experienceECCO '18 Vienna
2018
P569: Outcomes of IBD patients treated with infliximab: The impact of therapeutic drug monitoring in real-life clinical practiceECCO '18 Vienna
2018
P570: Improvements in subcomponents of the inflammatory bowel disease questionnaire in patients treated with vedolizumab: Results from GEMINI trial dataECCO '18 Vienna
2018
P572: Reactive dose escalation of infliximab in patients with Crohn’s disease in TAILORIX leads to improved outcomesECCO '18 Vienna
2018
P573: Safety and immune modulatory properties of etrasimod (APD334), a next-generation oral, selective sphingosine 1-phosphate receptor (S1PR) modulator, in healthy volunteersECCO '18 Vienna
2018
P574: The effects of vagus nerve stimulation in biologic-refractory Crohn’s disease: A prospective clinical trialECCO '18 Vienna
2018
P575: Vedolizumab trough levels predict clinical outcomes in inflammatory bowel diseaseECCO '18 Vienna
2018
P576: Impact of improved access to biologic therapies and physician engagement on excess steroid exposure: Results from a UK audit of 3561 patientsECCO '18 Vienna
2018
P577: A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s diseaseECCO '18 Vienna
2018
P578: Therapy refractory ulcerative colitis patients may benefit from appendectomy: long-term clinical results from a multicentre prospective cohort seriesECCO '18 Vienna
2018
P579: Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatmentsECCO '18 Vienna
2018
P581: Patient-reported complementary and alternative medicine use in IBD: 10 years of observation among patients included in a national cohortECCO '18 Vienna
2018
P584: Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnetECCO '18 Vienna
2018
P585: Impact of timing of thiopurine treatment on first intestinal resection in Crohn’s disease with poor prognostic factors: A nationwide population-based cohort study 2004–2015ECCO '18 Vienna
2018